Effects of growth hormone receptor antagonism and somatostatin analog administration on quality of life in acromegaly

Objective Acromegaly is associated with impaired quality of life (QoL). We investigated the effects of biochemical control of acromegaly by growth hormone receptor antagonism vs somatostatin analog therapy on QoL. Design Cross‐sectional. Patients 116 subjects: n = 55 receiving a somatostatin analog...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical endocrinology (Oxford) Vol. 94; no. 1; pp. 58 - 65
Main Authors:	Dichtel, Laura E., Kimball, Allison, Yuen, Kevin C. J., Woodmansee, Whitney, Haines, Melanie S., Guan, Qiu Xia, Swearingen, Brooke, Nachtigall, Lisa B., Tritos, Nicholas A., Sharpless, Julie L., Kaiser, Ursula B., Gerweck, Anu V., Miller, Karen K.
Format:	Journal Article
Language:	English
Published:	England Wiley Subscription Services, Inc 01-01-2021
Subjects:	Acromegaly Acromegaly - drug therapy Adult Aged Cross-Sectional Studies Female Growth hormones Human Growth Hormone Humans Insulin Insulin-Like Growth Factor I Insulin-like growth factors Male Middle Aged pegvisomant Quality of Life Receptors, Somatotropin Somatostatin Somatostatin - therapeutic use somatostatin analog acromegaly quality of life somatostatin analog pegvisomant
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!